Vyome Inc. (HIND)
NASDAQ: HIND
· Real-Time Price · USD
5.17
-0.24 (-4.44%)
At close: Sep 26, 2025, 3:59 PM
5.10
-1.35%
After-hours: Sep 26, 2025, 07:23 PM EDT
-4.44% (1D)
| Bid | 5.05 |
| Market Cap | 136.32M |
| Revenue (ttm) | 6.45M |
| Net Income (ttm) | -4.5M |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | -103.4 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 5.38 |
| Volume | 76,599 |
| Avg. Volume (20D) | 551,841 |
| Open | 5.50 |
| Previous Close | 5.41 |
| Day's Range | 5.04 - 5.50 |
| 52-Week Range | 5.04 - 720.00 |
| Beta | 1.03 |
| Ex-Dividend Date | n/a |
About HIND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HIND
Website n/a
1 week ago
+4.46%
Vyome Holdings shares are trading higher after the...
Unlock content with
Pro Subscription
1 month ago
+21.91%
Vyome Holdings shares are trading higher after the company signed an MoU with Embryyo Technologies to jointly pursue the l AI-enabled medical device market.
1 month ago · businesswire.com
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening BellCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Holdings (Nasdaq: HIND), a clinical-stage healthcare holding company targeting immuno-inflammatory and rare diseases in the US and global markets wit...
1 month ago · businesswire.com
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND TomorrowCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with l...
